Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

Vanthomme, Katrien; Vandenheede, Hadewijch; Hagedoorn, Paulien; Gadeyne, Sylvie

doi:10.1186/s12885-017-3461-8

Table 4 Trends between 1991 and 1997 and 2001–2008 in absolute and relative educational inequalities in site-specific cancer mortality among Belgian men aged 50–79 years

From: Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

Cancer site	Period	AMD ^a	PMD ^b	PAF ^c	RII ^d (95% CI) ^e
Total cancer mortality	1991–1997	49.4	−1.43	0.28	1.88 (1.81–1.95)
Total cancer mortality	2001–2011	49.4	−1.43	0.28	1.92 (1.85–1.99)
Head and neck	1991–1997	1.2	−8.67	0.32	2.35 (1.99–2.78)
Head and neck	2001–2011	1.2	−8.67	0.39	2.63 (2.23–3.10)
Oesophagus	1991–1997	0.3	2.38	0.14	1.34 (1.09–1.66)
Oesophagus	2001–2011	0.3	2.38	0.13	1.34 (1.13–1.59)
Stomach	1991–1997	13.6	23.68	0.47	3.05 (2.50–3.73)
Stomach	2001–2011	13.6	23.68	0.27	2.03 (1.66–2.47)
Colorectal	1991–1997	−1.8	−5.85	0.14	1.21 (1.08–1.36)
Colorectal	2001–2011	−1.8	−5.85	0.20	1.24 (1.20–1.50)
Liver	1991–1997	−0.2	−0.92	−0.02	1.04 (0.82–1.30)
Liver	2001–2011	−0.2	−0.92	0.03	1.06 (0.87–1.28)
Pancreas	1991–1997	−5.8	−14.68	−0.15	0.93 (0.78–1.10)
Pancreas	2001–2011	−5.8	−14.68	−0.01	1.15 (0.99–1.34)
Lung and trachea	1991–1997	44.6	−1.70	0.47	3.18 (2.98–3.39)
Lung and trachea	2001–2011	44.6	−1.70	0.47	3.34 (3.14–3.55)
Melanoma	1991–1997	−0.4	−12.53	−0.20	0.90 (0.57–1.41)
Melanoma	2001–2011	−0.4	−12.53	−0.07	0.79 (0.57–1.09)
Prostate	1991–1997	5.6	3.12	0.12	1.20 (1.06–1.36)
Prostate	2001–2011	5.6	3.12	0.10	1.17 (1.03–1.33)
Kidney	1991–1997	1.5	7.88	0.19	1.12 (0.89–1.40)
Kidney	2001–2011	1.5	7.88	0.11	1.16 (0.95–1.42)
Bladder	1991–1997	5.8	7.84	0.33	1.96 (1.62–2.38)
Bladder	2001–2011	5.8	7.84	0.28	1.70 (1.41–2.05)
Eye, brain, central nervous system	1991–1997	−3.2	−10.70	−0.10	0.91 (0.74–1.12)
Eye, brain, central nervous system	2001–2011	−3.2	−10.70	0.05	1.08 (0.87–1.34)
Non-Hodgkin Lymphoma	1991–1997	0.3	0.48	0.07	0.97 (0.77–1.23)
Non-Hodgkin Lymphoma	2001–2011	0.3	0.48	0.08	1.02 (0.81–1.27)
Multiple myeloma	1991–1997	0.1	−0.53	0.12	1.23 (0.90–1.68)
Multiple myeloma	2001–2011	0.1	−0.53	0.12	1.08 (0.83–1.42)
Leukaemia	1991–1997	−0.9	−4.69	0.03	1.10 (0.88–1.37)
Leukaemia	2001–2011	−0.9	−4.69	0.09	1.18 (0.96–1.44)

^aAbsolute Mortality Decline: Difference between low and high educated in absolute mortality decline: (ASMR_1990low - ASMR_2000low) - (ASMR_1990high - ASMR_2000high)
^bProportional Mortality Decline (in % points): Difference between low and high educated in proportional mortality decline: 100* (ASMR_1990low - ASMR_2000low)/ASMR_1990low - 100*(ASMR_1990high - ASMR_2000high)/ASMR_1990high
^cPopulation Attributable Fraction of education for mortality: (ASMR_tot - ASMR_high)/ASMR_tot
^dRelative Index of Inequality
^e95% Confidence Intervals

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us